Cargando…

Preliminary Evidence for the Cross-Cultural Utility of the Type D Personality Construct in the Ukraine

BACKGROUND: Type D personality is a risk indicator in cardiac patients. The validity and reliability of the Type D Scale (DS14) have been confirmed in Western Europe but not outside this context. PURPOSE: We examined the structural, convergent, and divergent validity and the reliability of the DS14...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedersen, Susanne S., Yagensky, Andriy, Smith, Otto R. F., Yagenska, Oksana, Shpak, Volodymyr, Denollet, Johan
Formato: Texto
Lenguaje:English
Publicado: Springer US 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707956/
https://www.ncbi.nlm.nih.gov/pubmed/19229633
http://dx.doi.org/10.1007/s12529-008-9022-4
Descripción
Sumario:BACKGROUND: Type D personality is a risk indicator in cardiac patients. The validity and reliability of the Type D Scale (DS14) have been confirmed in Western Europe but not outside this context. PURPOSE: We examined the structural, convergent, and divergent validity and the reliability of the DS14 in the Ukrainian setting. METHOD: Healthy Ukrainian respondents (n = 250) completed the DS14, the Eysenck Personality Questionnaire, the State Trait Anxiety Inventory, and the Beck Depression Inventory. A subsample (n = 57) completed the DS14 again after 4 weeks. RESULTS: The prevalence of Type D personality was 22.4%. The two-factor structure and the validity of the DS14 were confirmed. The DS14 subscales were internally consistent (Cronbach’s α = 0.86/0.71; mean inter-item correlation = 0.48/0.27) and stable over a 4-week period (r = 0.85/0.63). Type D individuals had significantly higher mean scores on anxiety (p < 0.001), depressive symptoms (p < 0.001), and negative affect (p < 0.001), and lower scores on positive affect (p < 0.001) compared to non-Type D individuals. CONCLUSION: Preliminary evidence suggests that the Ukrainian DS14 is a valid and reliable measure. Future studies are warranted to test the utility of the scale in cardiac patients in the Ukraine, including whether Type D also predicts adverse health outcomes beyond the boundaries of Western Europe.